Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Epitec.

Client Email

Product

Epitec
Lamivudine
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Epitec

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

65 API Suppliers, 34 USDMF, 21 CEP/COS, 5 JDMF, 21 EU WC, 9 KDMF, 19 NDC API, 37 Listed Suppliers, $ API Reference Price

65 API Suppliers
34 USDMF
21 CEP/COS
5 JDMF
21 EU WC
9 KDMF
19 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

21 API Suppliers

21 API Suppliers

FINISHED DOSAGE FORMULATIONS

1070 FDF Dossiers, 223 FDA Orange Book, 597 Europe, 38 Canada, 66 Australia, 76 South Africa, 70 Listed Dossiers

1070 FDF Dossiers
223 FDA Orange Book
597 Europe
38 Canada
66 Australia
76 South Africa
70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 150MG, TABLET;ORAL - 200MG, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 100MG
TABLET;ORAL - 150MG
TABLET;ORAL - 200MG
TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 25MG
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 5 Rochem International Inc, 22 SPI Pharma, 2 Seqens, 6 DKSH, 3 Jai Radhe Sales, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 16 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 3 Aeon Procare, 4 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 38 BASF, 1 Bioplus Life Sciences, 1 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 4 Doshion Polyscience, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 12 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 40 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 9 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 14 Seppic, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 3 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

107 Fillers, Diluents & Binders, 77 Coating Systems & Additives, 58 Direct Compression, 50 Disintegrants & Superdisintegrants, 45 Controlled & Modified Release, 39 Taste Masking, 34 Granulation, 32 Solubilizers, 28 Thickeners and Stabilizers, 27 Lubricants & Glidants, 23 Co-Processed Excipients, 22 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 19 Parenteral, 15 Topical, 8 API Stability Enhancers, 7 Emulsifying Agents, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules

107 Fillers, Diluents & Binders
77 Coating Systems & Additives
58 Direct Compression
50 Disintegrants & Superdisintegrants
45 Controlled & Modified Release
39 Taste Masking
34 Granulation
32 Solubilizers
28 Thickeners and Stabilizers
27 Lubricants & Glidants
23 Co-Processed Excipients
22 Film Formers & Plasticizers
22 Chewable & Orodispersible Aids
19 Parenteral
15 Topical
8 API Stability Enhancers
7 Emulsifying Agents
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 39 NEWS #PharmaBuzz

5 DATA COMPILATION #PharmaFlow
39 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 225 Finished Drug Prices, 10 Annual Reports

4 US Medicaid Prescriptions
225 Finished Drug Prices
10 Annual Reports

MARKET PLACE

9 APIs, 5 FDF Dossiers

9 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 6 Health Canada Patents

6 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 USP, 12 Others

4 EDQM
1 USP
12 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 132 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6GlaxoSmithKline Inc.

filter Patent Reset all filters

6 All

01 62277722

filter Product Reset all filters

6 All

01 6Lamotrigine

filter Dosage Reset all filters

6 All

01 6Chewable Dispersible Tablets

filter Exp Date Reset all filters

6 All

01 62012-01-29

IOL Lamotrigine

US Patents
Health Canada Patents

Product Main Page

01

GlaxoSmithKline Inc.

Lamotrigine

Formnext Forum

Not Confirmed

GlaxoSmithKline Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 5mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Lamotrigine

Formnext Forum

Not Confirmed

GlaxoSmithKline Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 25mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Lamotrigine

Formnext Forum

Not Confirmed

GlaxoSmithKline Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 50mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline Inc.

Lamotrigine

Formnext Forum

Not Confirmed

GlaxoSmithKline Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 100mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GlaxoSmithKline Inc.

Lamotrigine

Formnext Forum

Not Confirmed

GlaxoSmithKline Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 200mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GlaxoSmithKline Inc.

Lamotrigine

Formnext Forum

Not Confirmed

GlaxoSmithKline Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Lamotrigine

Brand Name : LAMICTAL

Patent Number : 2277722

Filing Date : 1992-01-29

Strength per Unit : 2mg

Dosage Form : Chewable Dispersible Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?